Skip to content
Article Rich – Lifestyle
Author:
Immunocine Cancer Center
Immunocine Cancer Center Expands as Demand Grows for Personalized Dendritic Cell Therapy
August 18, 2026
More Cancer Patients Are Opting to Preserve Their Tumors
August 13, 2026
Internationally Recognized Johns Hopkins Oncologist Dr. Stephen J. Noga Joins Immunocine as Chief Medical Officer
August 10, 2026